SEC Form SC 13G/A filed by Allena Pharmaceuticals Inc. (Amendment)
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be “filed” for the purpose of Section 18 of the Securities Exchange
Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act (however, see
the Notes).
CUSIP No. 018119107
|
|
(1) Names of reporting persons Point72 Asset Management, L.P.
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization Delaware
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 0 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 0 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
0 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 0% (see Item 4)
|
|
(12) Type of reporting person (see instructions) PN
|
CUSIP No. 018119107
|
|
(1) Names of reporting persons Point72 Capital Advisors, Inc.
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization Delaware
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 0 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 0 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
0 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 0% (see Item 4)
|
|
(12) Type of reporting person (see instructions) CO
|
CUSIP No. 018119107
|
|
(1) Names of reporting persons Steven A. Cohen
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization United States
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 0 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 0 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
0 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 0% (see Item 4)
|
|
(12) Type of reporting person (see instructions) IN
|
Management”) with respect to shares of common stock, par value $0.001 per share
(“Shares”), of the Issuer held by certain investment funds it manages; (ii)
Point72 Capital Advisors, Inc. (“Point72 Capital Advisors Inc.”) with respect
to Shares held by certain investment funds managed by Point72 Asset
Management; and (iii) Steven A. Cohen (“Mr. Cohen”) with respect to Shares
beneficially owned by Point72 Asset Management and Point72 Capital Advisors
Inc.
Point72 Capital Advisors Inc., and Mr. Cohen is 72 Cummings Point Road,
Stamford, CT 06902.
Advisors Inc. is a Delaware corporation. Mr. Cohen is a United States citizen.
directly no Shares. Pursuant to an investment management agreement, Point72
Asset Management maintains investment and voting power with respect to the
securities held by certain investment funds it manages. Point72 Capital Advisors
Inc. is the general partner of Point72 Asset Management. Mr. Cohen controls each
of Point72 Asset Management and Point72 Capital Advisors Inc. Each of Point72
Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen disclaims beneficial
ownership of any of the securities covered by this statement.
activities solely in connection with a nomination under§ 240.14a-11.